Back to Search
Start Over
Predictive value of soluble suppression of tumourigenicity 2 on myocardial reperfusion
- Source :
- Internal medicine journalReferences. 50(8)
- Publication Year :
- 2019
-
Abstract
- BACKGROUND High baseline level of soluble suppression of tumourigenicity 2 (sST2) was an independent predictor of cardiovascular death and heart failure in ST-segment elevation myocardial infarction (STEMI). AIMS To investigate the value of serum sST2 baseline levels in predicting myocardial reperfusion in patients with STEMI undergoing primary percutaneous coronary intervention (PPCI). METHODS Consecutive STEMI patients who underwent PPCI within 12 h after the onset of chest pain were enrolled, and were divided into Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grading (TMPG) 0/1/2 group and TMPG 3 group based on post-procedural TMPG. Baseline clinical characteristics, lesions and procedural characteristics were compared. Univariate logistic regression and multivariate linear logistic analysis were performed to identify independent predictors of impaired myocardial reperfusion (TMPG 0/1/2). Receiver-operating characteristics curve (ROC) analysis of sST2 was performed to identify the optimum cut-off value for predicting the myocardial reperfusion. RESULTS A total of 121 patients was enrolled in this study. Univariate logistic regression analysis showed that Killip II-III, high levels of sST2 and brain natriuretic peptide were risk factors of TMPG 0/1/2. Multivariable logistic regression analysis revealed that sST2 was an independent predictor of impaired myocardial reperfusion (odds ratio 12.318, 95% confidence interval 4.567-33.220, P
- Subjects :
- medicine.medical_specialty
medicine.medical_treatment
Myocardial Reperfusion
030204 cardiovascular system & hematology
Chest pain
Logistic regression
Coronary Angiography
03 medical and health sciences
0302 clinical medicine
Percutaneous Coronary Intervention
Internal medicine
Internal Medicine
Medicine
Humans
030212 general & internal medicine
Myocardial infarction
business.industry
Percutaneous coronary intervention
Odds ratio
Brain natriuretic peptide
medicine.disease
Prognosis
Heart failure
Cardiology
ST Elevation Myocardial Infarction
medicine.symptom
business
TIMI
Biomarkers
Subjects
Details
- ISSN :
- 14455994
- Volume :
- 50
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Internal medicine journalReferences
- Accession number :
- edsair.doi.dedup.....cf1a45af7b52985af08d0c01ff052f12